Medical DirectorPfizer Inc.Dorchester, Ontario, Canada
PB0518 - Coagulation biomarker levels in subjects with severe hemophilia receiving acute treatment for bleeding episodes experienced during prophylactic marstacimab treatment
Monday, June 24, 202413:45 – 14:45 ICT
